CHINA PHARMA HOLDINGS, INC. Prepaid Expense, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Prepaid Expense, Current of $86.97 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense, Current $86.97K.
- 2026-03-31: Prepaid Expense, Current $74.28K.
- 2025-12-31: Prepaid Expense, Current $82.37K.
- 2025-09-30: Prepaid Expense, Current $75.63K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2026-06-30 | $86.97K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $74.28K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $82.37K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $75.63K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $74.87K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $82.47K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $81.33K 10-K · filed 2026-04-01 |
| 2024-09-30 | $114.20K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $115.61K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $110.26K 10-K · filed 2025-03-31 |
| 2023-09-30 | $268.50K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $117.98K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $102.77K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $77.70K 10-K · filed 2024-04-01 |
| 2022-09-30 | $87.27K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $89.94K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $71.79K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $58.79K 10-K · filed 2023-03-30 |
| 2021-09-30 | $72.81K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $54.03K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $68.42K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $73.67K 10-K · filed 2022-03-30 |
| 2020-09-30 | $401.75K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $397.37K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $253.32K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $77.12K 10-K · filed 2021-03-26 |
| 2019-09-30 | $129.25K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $154.67K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $118.70K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $123.76K 10-K · filed 2020-03-30 |
| 2018-09-30 | $162.63K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $221.13K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $189.41K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $185.65K 10-K · filed 2019-03-28 |
| 2017-09-30 | $168.12K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $185.54K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $205.29K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $226.36K 10-K · filed 2018-04-02 |
| 2016-09-30 | $259.23K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $47.34K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $195.08K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $339.14K 10-K · filed 2017-03-31 |
| 2015-09-30 | $0.00 10-Q · filed 2015-12-28 |
| 2015-06-30 | $58.10K 10-Q · filed 2015-12-28 |
| 2015-03-31 | $231.64K 10-Q · filed 2015-12-28 |
| 2014-12-31 | $404.37K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |